A coronavirus vaccine likely will become available in the US through an emergency use authorization first, but the Food and Drug Administration still could demand the candidate meet the traditional safety and efficacy requirements, former FDA commissioner Scott Gottlieb said.
Gottlieb indicated during a webinar sponsored by the Personalized Medicine Coalition that the FDA could take advantage of the EUA’s...







